DOI:
10.1055/s-00000020
Geburtshilfe und Frauenheilkunde
LinksClose Window
References
Iwata H, Tamura K, Doi T. et al.
Trastuzumab deruxtecan (DS-8201a) in subjects with HER2-expressing solid tumors: Long-term results of a large phase 1 study with multiple expansion cohorts.
J Clin Oncol 2018;
36 (Suppl.) Abstr.. 2501
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.